Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus

Completed · Not applicable

Conditions studied: Type 2 Diabetes Mellitus

In brief

The purpose of this study is to determine if daily supplementation with 2000 International Units of Vitamin D will improve hemoglobin A1c in uncontrolled type 2 diabetics.

Key facts

Study ID

NCT00985361

Run by

ProMedica Health System

People needed

37

Starts

2009-10-01

Expected to finish

2010-03-01

Last updated by the study team

2010-05-06

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes mellitus
• Hemoglobin A1c >7% measured in the 3 months prior to randomization
• Age 21 to 75 years

You may not qualify if…

• Renal insufficiency (defined as CrCl <30mL/min)
• Gestational diabetes
• Malabsorption syndrome
• Patients taking vitamin D supplements at doses >400 international units daily

Where it is running

• Flower Hospital Family Medicine Residency — Sylvania, Ohio, United States
• Center for Health Services — Toledo, Ohio, United States
• Toledo Hospital Family Medicine Residency — Toledo, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.